Nomograms for prediction of prostate biopsy outcomes incorporating qualitative and quantitative findings of IMPROD biparametric MRI (IMPROD bpMRI consists of T2 weighted imaging and three separate DWI acquisitions) were developed using data of 161 men enrolled as a part of the single-institutional IMPROD (NCT01864135) trial and externally validated in 338 men enrolled as a part of the multi-institutional MULTI-IMPROD(NCT02241122) trial. A nomogram using IMPROD bpMRI findings had area under the curve values (95% confidence interval) of 0.92 (0.88-0.96), and 0.88 (0.84-0.92) in the development and validation cohorts, respectively, for the detection of prostate cancer with Gleason score 3+4 or higher.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords